肝硬化患者血小板-白细胞聚集增强且血小板输注后进一步增加
研究纳入19例肝硬化患者,在择期血小板输注前后检测血小板-白细胞聚集、活化及功能标志物。肝硬化患者血小板复合中性粒细胞较健康对照增加2.5倍,血小板复合白细胞活化标志物表达更高;血小板输注后血小板复合单核细胞频率及可溶性CD40配体升高。作者认为择期血小板输注可能加重肝硬化免疫功能障碍。
要点
- 肝硬化患者血小板复合中性粒细胞较健康对照增加2.5倍,血小板复合白细胞活化标志物表达更高。
- 择期血小板输注后血小板复合单核细胞频率升高(P<0.05),可溶性CD40配体升高。
- 作者认为择期血小板输注可能加重肝硬化免疫功能障碍。
核心结论
- 肝硬化患者循环中存在活化的血小板复合白细胞,择期血小板输注后血小板-单核细胞聚集增加,作者认为择期血小板输注可能加重肝硬化免疫功能障碍。
研究设计与样本
- 研究采集19例肝硬化患者择期血小板输注前后的血液,采用流式细胞术检测血小板-白细胞聚集、活化与功能,并以血栓弹力测定和血浆止血蛋白评估止血状态。
主要发现
- 肝硬化患者血小板复合中性粒细胞较健康受试者增加2.5倍,每个单核细胞和T细胞上附着的血小板数量为健康受试者的2倍。
- 所有血小板复合白细胞活化标志物表达水平更高,血小板复合中性粒细胞的静息氧化爆发和吞噬能力高于非血小板复合者(P<0.001),在肝硬化患者中最为明显。
- 血小板复合白细胞频率随MELD评分升高而下降。
- 血小板输注后血小板活化标志物可溶性CD40配体升高、血小板复合单核细胞频率升高(P<0.05),止血状态改善。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Thrombocytopenia and circulating dysfunctional immune cells are commonly observed in patients with cirrhosis. Platelets may form complexes with neutrophils, monocytes and T cells modulating their function. We recently reported increased frequencies of platelet-complexed neutrophils in cirrhosis with evidence of neutrophil activation upon contact with healthy platelets in vitro. Whether this occurs in vivo following platelet transfusion and contributes to systemic inflammation and endothelial activation is unknown. AIMS: To characterise platelet-leucocyte aggregation in cirrhosis and to determine whether elective platelet transfusion results in perturbations associated with changes in markers of haemostasis, inflammation or endothelial activation. METHODS: We collected blood from cirrhotics (n = 19) before and following elective platelet transfusion. We measured platelet-leucocyte aggregation, activation and function, and markers of platelet activation, systemic inflammation and endothelial activation by flow cytometry. Haemostasis was assessed by thromboelastometry and plasma haemostatic proteins. RESULTS: We observed a 2.5-fold increase in platelet-complexed neutrophils in patients with cirrhosis compared with healthy subjects and twofold more platelets attached per monocyte and T cell. All platelet-complexed leucocytes expressed higher levels of activation markers and platelet-complexed neutrophils had higher resting oxidative burst and phagocytic capacity than their nonplatelet-complexed counterparts (P < 0.001); most pronounced in patients with cirrhosis. Paradoxically, platelet-complexed leucocyte frequency decreased with increasing MELD score. Platelet transfusion increased soluble CD40 ligand (platelet activation marker), the frequency of platelet-complexed monocytes (P < 0.05) and improved haemostatic status. CONCLUSION: Cirrhotic patients have activated circulating platelet-complexed leucocytes with increased platelet-monocyte aggregation following elective platelet transfusion. Elective platelet transfusion might therefore exacerbate immune dysfunction in cirrhosis.
引用
- Støy S, Patel VC, Sturgeon JP, et al. Platelet-leucocyte aggregation is augmented in cirrhosis and further increased by platelet transfusion. Aliment Pharmacol Ther. 2018. PMID: 29528132. doi:10.1111/apt.14600
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。